Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

PURPOSE: Sunitinib in combination with docetaxel enhances antitumor activity in xenograft models of human breast and non-small cell lung cancer. We assessed the maximum tolerated doses (MTDs), safety, pharmacokinetic profiles, and preliminary efficacy of sunitinib plus docetaxel in patients with adv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Robert, Francisco, Sandler, Alan, Schiller, Joan H., Liu, Glenn, Harper, Karen, Verkh, Lev, Huang, Xin, Ilagan, Jennifer, Tye, Lesley, Chao, Richard, Traynor, Anne M.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2009
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2904454/
https://ncbi.nlm.nih.gov/pubmed/20043166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-009-1209-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados